Prognostic Impact of Functional Mitral Regurgitation in Patients Admitted With Acute Decompensated Heart Failure
Yuko Wada(Shiga University of Medical Science), Toshihisa Anzai(Hokkaido University), Satoshi Yasuda(Tohoku University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Takuya Hasegawa(Tokyo Institute of Technology), Hiroyuki Yokoyama(Honda (Japan)), Yasuo Sugano(keiyu Hospital), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Akira Funada(National Cerebral and Cardiovascular Center)
Cited by 27
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755